FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Saquinavir Mesylate (Invirase) 200mg Capsules
Status: Discontinuation
»Therapeutic Categories: Antiviral

Genentech, Inc (New 02/06/2018)

Company Contact Information:

Presentation Posting Date Related Information
200 mg capsules (NDC 0004-0245-15) 02/06/2018 Roche intends to stop-shipping Saquinavir Mesylate (Invirase) 200 mg Capsules on March 31, 2018 with product availability continuing until the September 2018 expiry date. Saquinavir Mesylate (Invirase) 500mg Tablets are still available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English